Zoom’s new AI Companion web surface leverages work conversations to help save time and boost productivity Personal workflows (beta), AI Companion 3.0 features for Zoom Docs (coming soon), and agentic AI features enhance work quality and streamline content creation Free-tier and standalone plans enable Zoom Basic users to try AI
Datavault AI’s International Name, Image and Likeness (“NIL”) Exchange will Solve for Regulatory Compliant with Quantum Encrypted Smart Contracts that will Present the Winning Solution PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Datavault AI Inc. (NASDAQ: DVLT; the “Company” or “Datavault AI”), a leading provider of patented agentic AI platforms
Zoom launches AI Companion 3.0 with agentic workflows, transforming conversations into action Leave a reply Zoom’s new AI Companion web surface leverages work conversations to help save time and boost productivity Personal workflows (beta), AI Companion 3.0 features for Zoom Docs (coming soon), and agentic AI features enhance work quality
Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange Leave a reply Datavault AI’s International Name, Image and Likeness (“NIL”) Exchange will Solve for Regulatory Compliant with Quantum Encrypted Smart Contracts that will Present the Winning Solution PHILADELPHIA, Dec.
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline.
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline.
INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor